[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340516-105":59,"doc-detail-340516-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prevalence-and-in-vitro-study-of-human-polyomavirus-9","Prevalence and in vitro study of human polyomavirus 9","","Human polyomavirus 9 (HPyV9) remains poorly characterized, including its transmission routes and replication sites. A seroprevalence analysis of 1038 serum samples from ages 0.7–93 years showed age-associated seropositivity, with 36.2% adult seroprevalence. Tissue and respiratory-tract sampling revealed detection in 5.2% of nasopharyngeal specimens and 1% of tonsils. Viral promoter regulation and large T antigen effects were tested across multiple respiratory, kidney, endothelial, and colon cell systems.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prevalence-and-in-vitro-study-of-human-polyomavirus-9/340516/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prevalence-and-in-vitro-study-of-human-polyomavirus-9/340516.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the seroprevalence study show for HPyV9 across ages?","Question",{"text":112,"@type":113},"Seropositivity increased with age among children and young adults, and adult seroprevalence reached 36.2%.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Where was HPyV9 detected in respiratory-tract and related samples?",{"text":117,"@type":113},"HPyV9 was detected in 5.2% of nasopharyngeal samples and 1% of tonsils, based on the examined respiratory-tract specimen types.",{"name":119,"@type":110,"acceptedAnswer":120},"How were HPyV9 promoter activity and the role of large T antigen assessed?",{"text":121,"@type":113},"Early and late promoter activities were measured in multiple cell lines and airway epithelial systems, and large T antigen expression significantly increased the late promoter activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340516,1790333811,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPrevalence and in vitro study of human polyomavirus 9  \nMelinda Katona1,2,4, Krisztina Jeles1,2,4, Péter Takács3 & Eszter Csoma2􀀍  \nLittle is known about human polyomavirus 9 (HPyV9). The mode of transmission and the site of replication are unknown, and seroprevalence data have been published with a wide range. A total of 1038 serum samples from individuals aged 0.7–93 years were used for seroprevalence study. We observed that seropositivity increased with age among children and young adults, and a 36.2% adultseroprevalence was detected. The prevalence was examined in samples from the respiratory tract: cancerous and non-cancerous lung tissues, tonsils, adenoids, throat swabs, middle ear discharge and nasopharyngeal samples collected from children and adults. HPyV9 was detected in 5.2% of nasopharyngeal samples and 1% of tonsils. Upon a viral infection, the interaction of viral promotersand cellular factors may determine whether a virus productively replicates in a cell. The early and late promoter activity of HPyV9 and the effect of the large T antigen (LTAg) on it was investigated in respiratory, kidney, endothelial and colon cell lines, fibroblast and primary airway epithelial cells. The highest promoter activity was measured inA549 lung cell line. LTAg expression significantly increased the late promoter activity. Based on our results, the respiratory cells may be suitable for HPyV9 replication.  \nKeywords HPyV9, Seroprevalence, DNA prevalence, Promoter activities, Respiratory tract  \nBackground  \nMore than a decade after its discovery1, the clinical significance of human polyomavirus 9 (HPyV9) has remained unclear. Although DNA and seroprevalence studies started immediately, the answers to many fundamental questions remain unknown.  \nIt is still unclear how frequent the HPyV9 infection is in the human population. According to seroprevalence studies, there is an increase in seroprevalence with age during childhood, and the adult seropositivity ranged between 11–47%2–12. In addition to the large differences in the data, there was also a difference in how the positivity rates changed with age among adults. Nicol et al. reported that HPyV9 infections occurred throughout life, and that the seropositivity rate increased with age, reaching a maximum of 70% in individuals over 80 years of age3,4. Nevertheless, others published that adulthood seropositivity remained relatively stable or only moderately increased8, 10, 11, or it even declined with aging2,5,7.  \nThe mode of transmission and the portal of entry for HPyV9 are still unknown. After the discovery of HPyV9 in the serum sample of an immunocompromised kidney transplant patient1, the viral DNA was detected with a low prevalence rate in blood1,6, 13–17, urine1, 16, 17, respiratory samples16, 17, lung autopsy tissue17, tonsils18, and skin samples17, 19–24. At the same time, others did not observe HPyV9 DNA in blood25,26, urine26–28, respiratory samples19,26, tonsils29–31, cerebrospinal fluid26,32, feces26, or skin samples33,34. Entry of the virus into the body through the oral cavity, respiratory tract, or skin is only a hypothesis.  \nImmunosuppression and organ transplantation may increase the risk of HPyV9 infection. Compared with that in healthy blood donors, not only is HPyV9 viremia significantly greater after kidney transplantation6, but a significant increase in the HPyV9 seropositivity rate was also observed among the transplant patients compared with healthy control group6,35. However, it should be noted that HPyV9 was not detected in blood, urine, and respiratory swab samples from kidney transplant patients in another prospective, longitudinal study36. Similarly, the virus was not found in blood samples of allogenic hematopoietic stem cell transplant recipients for one year post-transplant37. In a case series study, HPyV9 was the only pathogen detected in the widespread, hyperkeratotic sk","cbCaiaHrzpL9y6GR","https://ap.wps.com/l/cbCaiaHrzpL9y6GR","pdf",3385092,16,"English","# Background\n# Seroprevalence and age-related patterns\n# Transmission routes and entry portal (evidence and hypotheses)\n# Association with immunosuppression and organ transplantation\n# Oncogenic potential and tumor association\n# In vivo cell tropism, replication constraints, and promoter regulation","[{\"question\":\"What did the seroprevalence study show for HPyV9 across ages?\",\"answer\":\"Seropositivity increased with age among children and young adults, and adult seroprevalence reached 36.2%.\"},{\"question\":\"Where was HPyV9 detected in respiratory-tract and related samples?\",\"answer\":\"HPyV9 was detected in 5.2% of nasopharyngeal samples and 1% of tonsils, based on the examined respiratory-tract specimen types.\"},{\"question\":\"How were HPyV9 promoter activity and the role of large T antigen assessed?\",\"answer\":\"Early and late promoter activities were measured in multiple cell lines and airway epithelial systems, and large T antigen expression significantly increased the late promoter activity.\"}]","Prevalence and in vitro study of human polyomavirus 9 | PDF",1790036998,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87ab3edc9bdcd8b0080d1a5541cea0bb.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ab4f8f3434297537eae80552f141d3b.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba1edd956aaf9a9410666863a591e1e7.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f986cef96208d4110126e19a4d0056b6.webp",980,1287]